These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13319685)

  • 1. Further experiments with the soluble antigen of the MEF1 poliomyelitis virus.
    SELZER G; VAN DEN ENDE M
    J Hyg (Lond); 1956 Mar; 54(1):1-7. PubMed ID: 13319685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative relationships between antigen concentration and serum titer in poliomyelitis virus neutralization test].
    DREES O; ROHDE B
    Zentralbl Bakteriol Orig; 1956 Jun; 166(2):84-9. PubMed ID: 13353534
    [No Abstract]   [Full Text] [Related]  

  • 3. The electrophoretic mobilities of adapted MEF1 poliomyelitis virus and its soluble antigen.
    POLSON A; SELZER G; VAN DEN ENDE M
    Biochim Biophys Acta; 1957 Jun; 24(3):600-3. PubMed ID: 13436485
    [No Abstract]   [Full Text] [Related]  

  • 4. Appearance of soluble and cross-reactive complement-fixing antigens on treatment of poliovirus with formalin.
    BLACK FL; MELNICK JL
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):353-5. PubMed ID: 13254758
    [No Abstract]   [Full Text] [Related]  

  • 5. The adaptation of poliomyelitis virus, Lansing strain, to newborn mice and the use of their central nervous tissues for preparation of complement-fixing antigen.
    CASALS J; OLITSKY PK
    Arch Gesamte Virusforsch; 1951; 4(4):452-9. PubMed ID: 13249481
    [No Abstract]   [Full Text] [Related]  

  • 6. The production of antibodies in cotton rats by living and killed poliomyelitis viruses.
    TOBIN JO
    Br J Exp Pathol; 1956 Apr; 37(2):161-7. PubMed ID: 13315891
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on serum from aborigines in the Northern territory of Australia. III. Antibodies against brunhilde (type I) and leon (type III) poliomyelitis viruses.
    STOKES LJ; AMES PG; MILES JA
    Med J Aust; 1955 Sep; 42(12):433-8. PubMed ID: 13264884
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of a non-infective antigen from preparations of poliomyelitis virus.
    AGOL VI; CHUMAKOVA MIa
    Probl Virol; 1961; 6():175-8. PubMed ID: 14036593
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralizing antibody to viruses of poliomyelitis in sera of domestic animals.
    BARTELL P; KLEIN M
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):597-601. PubMed ID: 13289848
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliovirus as an antigen.
    STEVENS KM
    J Hyg (Lond); 1957 Dec; 55(4):489-93. PubMed ID: 13491837
    [No Abstract]   [Full Text] [Related]  

  • 11. A phase contrast microprecipitin test with poliovirus antigens. I. Properties of the antigens and antibodies and optimum conditions for reaction.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():120-51. PubMed ID: 13725916
    [No Abstract]   [Full Text] [Related]  

  • 12. [The microflocculation reaction, on slides using the agar double diffusion technic, between poliomyelitis antigens and antibodies. II. Comparative study of the neutralizing, complement-fixing and flocculation antibodies].
    PACCAUD MF; PONGRATZ E; SCHLAEPFER J
    Arch Gesamte Virusforsch; 1960; 10():351-60. PubMed ID: 13731895
    [No Abstract]   [Full Text] [Related]  

  • 13. The behavior of different strains of poliomyelitis virus in the complement fixation reaction. III. Comparison of the potency of complement fixing antigens derived from different strains of poliomyelitis virus.
    SCHMIDT NJ; LENNETTE EH; DENNIS J; HAGENS SJ
    J Immunol; 1960 Jul; 85():67-71. PubMed ID: 14443080
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isolation of infectious antigens from poliomyelitis virus preparations].
    AGOL VI; CHUMAKOVA MIa
    Vopr Virusol; 1961; 6():161-6. PubMed ID: 13681646
    [No Abstract]   [Full Text] [Related]  

  • 15. [The microflocculation reaction, on slides using the agar double diffusion technic, between poliomyelitis antibodies and antigens. I. Study of the reaction].
    PACCAUD MF; PONGRATZ E; SCHLAEPFER J
    Arch Gesamte Virusforsch; 1960; 10():335-50. PubMed ID: 13731894
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigations of poliomyelitis antigens.
    POLSON A; EHRENBERG A; CRAMER R
    Biochim Biophys Acta; 1958 Sep; 29(3):612-22. PubMed ID: 13584365
    [No Abstract]   [Full Text] [Related]  

  • 17. [Precipitation antibodies against poliovirus in patients with poliomyelitis].
    Ruiz-Gómez J; Bustamante ME
    Arch Invest Med (Mex); 1977; 8(2):103-12. PubMed ID: 199122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement fixing antibodies in guinea pigs after inoculation of poliovirus antigens.
    PAPAPANAGIOTOU J; VON MAGNUS H
    Acta Pathol Microbiol Scand; 1962; 54():99-106. PubMed ID: 14483691
    [No Abstract]   [Full Text] [Related]  

  • 19. The measurement of the D-antigen in poliovirus preparations.
    BEALE AJ; MASON PJ
    J Hyg (Lond); 1962 Mar; 60(1):113-21. PubMed ID: 13866112
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the complement-fixing antigens of poliomyelitis. III. Intracellular development of antigen.
    HINUMA Y; HUMMELER K
    J Immunol; 1961 Oct; 87():367-75. PubMed ID: 13907581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.